ENTA logo

ENTA

Enanta Pharmaceuticals, Inc.NASDAQHealthcare
$13.14+1.31%ClosedMarket Cap: $305.1M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-10HC Wainwright & Co.Buy
2026-01-09HC Wainwright & Co.Buy
2025-10-01JefferiesBuy
2025-09-30WestPark CapitalBuy
2025-09-15Evercore ISI GroupOutperform
2025-08-12JMP SecuritiesMarket Outperform
2025-06-03JMP SecuritiesMarket Outperform
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Sep 30$-1.99$63.1M4
Sat Sep 30$-2.18$64.7M3
Sun Sep 30$-1.63$68.0M1
Mon Sep 30$-2.19$57.1M1